Jan 02, 2026
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.19 to $0.01.
The split itself did not change the total investment value.
Co-Diagnostics, Inc. (CODX) trades on the NASDAQ in the Biotechnology industry.
Co-Diagnostics, Inc. company overviewThe latest split shown was on January 2, 2026. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
This history records one reverse split, on January 2, 2026.